Mylan Inc (NASDAQ:MYL) on Thursday announced that its subsidiary Agila Specialties Private Limited is conducting a voluntary nationwide recall in the US to the hospital/user level certain lots Etomidate Injection, which is used for induction of general anaesthesia. Mylan Inc (NASDAQ:MYL) stock opened at $50.98 in last session, and closed at $52.26, while the day range of stock is $50.55 – $52.44. The stock showed a positive weekly performance of 14.48%.
Zacks lowered shares of Novo Nordisk A/S (ADR) (NYSE:NVO) from an outperform rating to a neutral rating in a report released on Monday, AnalystRatingsNetwork.com reports. Novo Nordisk A/S (ADR) (NYSE:NVO) stock opened at $44.00, in last session and closed at $44.42, by gaining 0.75%. The 52 week range of the stock is $29.90 – $44.57. Company’s market capitalization is $117.96 billion.
Enzo Biochem, Inc. (NYSE:ENZ) Clinical Labs and Nuclea Biotechnologies have entered into an agreement to market Nuclea’s non-invasive HER-2/neu serum test for monitoring metastatic breast cancer, Enzo Biochem announced today. Enzo Biochem, Inc. (NYSE:ENZ) stock advanced 11.70% and finished the last session at $4.01. The EPS of the stock remained -0.44. Company’s market capitalization is $165.81 million.
Actavis plc Ordinary Shares (NYSE:ACT), posted its fourth quarter results for the period ending 31, 2013 that show a 59% increase in revenue of $2.78 billion for the quarter, compared to 4Q 2012 revenues of $1.75 billion. This was the most successful year for Actavis that saw it acquire Warner Chillicot plc.While also becoming a global premier leader in pharmaceutical. Actavis plc Ordinary Shares (NYSE:ACT) stock opened the session at $211.45, and closed the session at $220.37. The 52 week range of the stock remained $82.02 – $222.24 and the day range was $ 210.49 -$222.24.
Leave a Reply